# EDGAR Filing Document

**Accession Number:** 0000863894
**File Stem:** 0001193125-23-087210
**Filing Date:** 2023-3
**Character Count:** 7264
**Document Hash:** f5fc452d477c8b43d4465e0835d84b54
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-087210.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001193125-23-087210

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230328

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VERU INC.
- **CENTRAL INDEX KEY:** 0000863894
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 391144397
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13602
- **FILM NUMBER:** 23784583

**BUSINESS ADDRESS:**
- **STREET 1:** 2916 N. MIAMI AVENUE
- **STREET 2:** SUITE 1000
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33127
- **BUSINESS PHONE:** 3125959123

**MAIL ADDRESS:**
- **STREET 1:** 2916 N. MIAMI AVENUE
- **STREET 2:** SUITE 1000
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33127

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEMALE HEALTH CO
- **DATE OF NAME CHANGE:** 19960205

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WISCONSIN PHARMACAL COMPANY INC
- **DATE OF NAME CHANGE:** 19920703

?xml version="1.0" encoding="utf-8" ? 8-K

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### FORM 8-K

------

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): March 28, 2023

------

## VERU INC.

#### (Exact name of registrant as specified in its charter)

------

---

| | | |
|:---|:---|:---|
| **Wisconsin** | **1-13602** | **39-1144397** |
| **(State or other jurisdiction<br>of incorporation)** | **(Commission<br>File Number)** | **(IRS Employer<br>Identification No.)** |

---

#### 2916 North Miami Avenue, Suite 1000, Miami, Florida 33127

#### (Address of principal executive offices) (Zip Code)

#### Registrant's telephone number, including area code: (305) 509-6897

#### Not Applicable

#### (Former name or former address, if changed since last report.)

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange<br>on which registered** |
| Common Stock, $0.01 par value per share | VERU | NASDAQ Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07.** | **Submission of Matters to a Vote of Security Holders.**  |

---

Veru Inc. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting") on March 28, 2023. A total of 80,623,128 shares of the Company's common stock were eligible to vote at the Annual Meeting. The matters voted on at the Annual Meeting were as follows:

1. Election of Directors:

The following individuals were nominated for election to the Board of Directors for terms that expire at the next annual meeting of shareholders. All of the nominated directors were elected. The results of the vote on the election of directors were as follows:

---

| | | | |
|:---|:---|:---|:---|
| Name | Votes<br>For | Votes<br>Withheld | Broker<br>Non-Votes |
|  Mitchell S. Steiner | 29191998 | 1455034 | 23956639 |
|  Mario Eisenberger | 25788030 | 4859002 | 23956639 |
|  Harry Fisch | 29672413 | 974619 | 23956639 |
|  Lucy Lu | 29992620 | 654412 | 23956639 |
|  Michael L. Rankowitz | 29141142 | 1505890 | 23956639 |
|  Grace Hyun | 29919476 | 727556 | 23956639 |

---

2. Ratification of Auditors:

The shareholders voted to ratify the appointment by the Company's Audit Committee of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2023.

---

| | | | |
|:---|:---|:---|:---|
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
| 53756041 | 755323 | 92307 | 0 |

---

3. Advisory (non-binding) vote on the executive compensation of the Company's named executive officers:

The shareholders voted in favor of the compensation of the Company's named executive officers as disclosed in the proxy statement for the Annual Meeting.

---

| | | | |
|:---|:---|:---|:---|
| Votes For | Votes Against | Abstentions | Broker Non-Votes |
| 23827107 | 6372045 | 447880 | 23956639 |

---

4. Advisory (non-binding) vote on the frequency of the advisory vote on the executive compensation of the Company's named executive officers:

The shareholders voted to recommend that the Company include an advisory vote on the compensation of the Company's named executive officers pursuant to the rules of the Securities and Exchange Commission every three years.

---

| | | | | |
|:---|:---|:---|:---|:---|
| One Year | Two Years | Three Years | Abstentions | Broker Non-Votes |
| 10382149 | 337226 | 19404952 | 522705 | 23956639 |

---

In accordance with the shareholder voting results, in which every "Three Years" received the highest number of votes cast on the frequency proposal, and the Board of Directors' recommendation in the Proxy Statement for the Annual Meeting, the Company's Board of Directors has determined that future shareholder non-binding advisory votes on executive compensation will occur every three years. Accordingly, the next shareholder non-binding advisory vote on executive compensation will be held at the Company's 2026 Annual Meeting of Shareholders. The next required shareholder non-binding advisory vote regarding the frequency interval will be held in six years at the Company's 2029 Annual Meeting of Shareholders.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: March 31, 2023 | VERU INC. | VERU INC. |
|  | By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Michele Greco |
|  |  | Michele Greco |
|  |  | Chief Financial Officer and Chief Administrative Officer |

---